Literature DB >> 16143432

Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice.

Peter Pushko1, Terrence M Tumpey, Fang Bu, John Knell, Robin Robinson, Gale Smith.   

Abstract

Avian influenza viruses represent a growing threat for an influenza pandemic. To develop recombinant vaccine for avian influenza of the H9N2 subtype, we expressed in insect cells virus-like particles (VLPs) consisting of three structural proteins of influenza A/Hong Kong/1073/99 (H9N2) virus. Upon infection of Sf9 cells with recombinant baculoviruses, the hemagglutinin (HA), neuraminidase (NA), and matrix (M1) proteins were co-expressed in the infected cells, self-assembled, and released into the culture medium as VLPs of 80-120nm in diameter. VLPs exhibited functional characteristics of influenza virus including hemagglutination and neuraminidase activities. In BALB/c mice, VLPs elicited serum antibodies specific for influenza A/Hong Kong/1073/99 (H9N2) virus and inhibited replication of the influenza virus after challenge. Thus, VLPs represent a potential strategy for the development of human vaccines against avian influenza H9N2 viruses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16143432     DOI: 10.1016/j.vaccine.2005.07.098

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  94 in total

1.  Sequence and phylogenetic analysis of surface protein genes of emerging H9N2 influenza viruses isolated from poultry in two geographical regions of China.

Authors:  Yu Xue; Jing-Lan Wang; Zhuan-Qiang Yan; Guang-Wei Li; Shun-Yan Chen; Xiang-Bin Zhang; Jian-Ping Qin; Hai-Yan Li; Shuang Chang; Feng Chen; Ying-Zuo Bee; Qing-Mei Xie
Journal:  Virus Genes       Date:  2014-03-30       Impact factor: 2.332

2.  Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus.

Authors:  Fu-Shi Quan; Chunzi Huang; Richard W Compans; Sang-Moo Kang
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

Review 3.  Traditional and new influenza vaccines.

Authors:  Sook-San Wong; Richard J Webby
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

4.  Multi-clade H5N1 virus-like particles: Immunogenicity and protection against H5N1 virus and effects of beta-propiolactone.

Authors:  Peter Pushko; Irina Tretyakova; Rachmat Hidajat; Xiangjie Sun; Jessica A Belser; Terrence M Tumpey
Journal:  Vaccine       Date:  2018-06-07       Impact factor: 3.641

Review 5.  Progress in developing virus-like particle influenza vaccines.

Authors:  Fu-Shi Quan; Young-Tae Lee; Ki-Hye Kim; Min-Chul Kim; Sang-Moo Kang
Journal:  Expert Rev Vaccines       Date:  2016-05-05       Impact factor: 5.217

6.  Immunogenicity of H1N1 influenza virus-like particles produced in Nicotiana benthamiana.

Authors:  Yoko Shoji; Alex Prokhnevsky; Brett Leffet; Nancy Vetter; Stephen Tottey; Shama Satinover; Konstantin Musiychuk; Moneim Shamloul; Joey Norikane; R Mark Jones; Jessica A Chichester; Brian J Green; Stephen J Streatfield; Vidadi Yusibov
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

7.  Mono- and quadri-subtype virus-like particles (VLPs) containing H10 subtype elicit protective immunity to H10 influenza in a ferret challenge model.

Authors:  Peter Pushko; Xiangjie Sun; Irina Tretyakova; Rachmat Hidajat; Joanna A Pulit-Penaloza; Jessica A Belser; Taronna R Maines; Terrence M Tumpey
Journal:  Vaccine       Date:  2016-09-20       Impact factor: 3.641

8.  Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge.

Authors:  Zhiyuan Wen; Ling Ye; Yulong Gao; Lei Pan; Ke Dong; Zhigao Bu; Richard W Compans; Chinglai Yang
Journal:  Antiviral Res       Date:  2009-09-20       Impact factor: 5.970

9.  Virus-like particles containing multiple M2 extracellular domains confer improved cross-protection against various subtypes of influenza virus.

Authors:  Min-Chul Kim; Jae-Min Song; Eunju O; Young-Man Kwon; Youn-Jeong Lee; Richard W Compans; Sang-Moo Kang
Journal:  Mol Ther       Date:  2012-12-18       Impact factor: 11.454

10.  Protection against lethal challenge by Ebola virus-like particles produced in insect cells.

Authors:  Yuliang Sun; Ricardo Carrion; Ling Ye; Zhiyuan Wen; Young-Tae Ro; Kathleen Brasky; Anysha E Ticer; E Ellen Schwegler; Jean L Patterson; Richard W Compans; Chinglai Yang
Journal:  Virology       Date:  2008-11-04       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.